Valeant’s Rebound Falters After Key Drug Is Rejected
Valeant Pharmaceuticals International Inc.'s rebound from this year's low in March was stopped in its tracks after U.S. regulators rejected its application for a plaque psoriasis lotion, Duobrii, that management saw as the first of many new drugs to hit the market in the next few years. Trading volume was more than 1.5 times the full-day average of the past three months as investors retreated even after the company pointed out that the Food and Drug Administration's ruling was related to its pharmacokinetic data and said management is working to “resolve this matter expeditiously” and has already requested a meeting with regulators. Wells Fargo analyst David Maris warned that an approval may be delayed by six to nine months depending on Valeant's need to generate additional data.
A bullish options trade brewing in Starbucks
"Halftime Report" trader Pete Najarian spots heavy call-buying in Starbucks and JD.com.
Alibaba Group Holding Ltd Stock Still Has Cloud-Driven Upside
Think the 56% advance Alibaba Group Holding Ltd (NYSE:BABA) shares have dished out over the course of the past 12 months means BABA stock has no more room to run? Wells Fargo analyst Ken Sena doesn't agree. It's a largely overlooked facet of Alibaba, which is most often likened to Amazon.com, Inc. (NASDAQ:AMZN) because of its e-commerce presence.
10 Best Stocks Under $10
Good things come in small packages goes the saying. Nowhere is that truer than in the markets where stocks under $10 grow to be $100 and possibly even $1,000 over time.
Why Intel Stock Slid 5% This Morning
Northland Capital downgrades on servers concerns.
It would be incredibly difficult for California to split into three states. If it did, here's how it would work
Northern California, California, and Southern California — has qualified to appear on the ballot in November's general election. The Cal 3 ballot measure received more than 400,000 valid signatures, thanks to financial backing from Silicon Valley investor Tim Draper. It's still unclear if cutting up California into three states is legal and if Cal 3 could muster enough support from California voters and US Congress.
